Similar Articles
41 Persistent elevation of fibrosis biomarker cartilage oligomeric matrix protein following hepatitis C virus eradication
42 European Association for the Study of the Liver and French hepatitis C recent guidelines: The paradigm shift
43 Spleen stiffness mirrors changes in portal hypertension after successful interferon-free therapy in chronic-hepatitis C virus patients
44 Hepatitis C virus related cirrhosis decreased as indication to liver transplantation since the introduction of direct-acting antivirals: A single-center study
45 Hepatitis C resistance to NS5A inhibitors: Is it going to be a problem?
46 Hepatitis B reactivation in patients receiving direct-acting antiviral therapy or interferon-based therapy for hepatitis C: A systematic review and meta-analysis
47 Systematic overview of hepatitis C infection in the Middle East and North Africa
48 Epidemiological features of chronic hepatitis C infection caused by remunerated blood donors: A nearly 27-year period survey
49 Fatty liver in hepatitis C patients post-sustained virological response with direct-acting antivirals
50 Predictors of functional benefit of hepatitis C therapy in a ‘real-life’ cohort
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA